Evidence map›Paper›PMID 9763437›Full record

ArticleThe Journal of cell biology1998

Fibronectin matrix regulates activation of RHO and CDC42 GTPases and cell cycle progression.

S Bourdoulous, G Orend, D A MacKenna, R Pasqualini, E Ruoslahti

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of cell biology, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 230 citations in OpenAlex.

  1. Article
  2. Peptides for Coating TiOInternational journal of molecular sciences · 2022
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 4 countries.

S BourdoulousCancer Research Center, The Burnham Institute, La Jolla, California 92037, USA.
G Orend
D A MacKenna
R Pasqualini
E Ruoslahti
Cancer Research Center · USSpanish Oncology Genitourinary Group · ES

Funding

Tumor Microenvironment and Cancer ImmunologyP30CA030199 · NCI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI Michael Jackson · 1985 to 2026
$107.2M
ALPHA 5 BETA 1 INTEGRIN IN FIBRONECTIN MATRIX ASSEMBLYF32CA067424 · NCI · BURNHAM INSTITUTE FOR MEDICAL RESEARCH · PI MACKENNA, DEIDRE A · 1995 to 1997
–
FIBRONECTIN MATRIX--ASSEMBLY AND ROLE IN MALIGNANCYR01CA062042 · NCI · BURNHAM INSTITUTE FOR MEDICAL RESEARCH · PI RUOSLAHTI, ERKKI I · 1994 to 1998
–
INTEGRIN SIGNALING THROUGH INSULIN RECEPTOR SUBSTRATER01CA067224 · NCI · BURNHAM INSTITUTE FOR MEDICAL RESEARCH · PI RUOSLAHTI, ERKKI I · 1995 to 1999
–
NCI NIH HHS CA30199NCI NIH HHS CA62042NCI NIH HHS CA67224NCI NIH HHS F32 CA067424NCI NIH HHS P30 CA030199
6 · The paper itself

Abstract

Adherent cells assemble fibronectin into a fibrillar matrix on their apical surface. The fibril formation is initiated by fibronectin binding to the integrins alpha5 beta1 and alphav beta3, and is completed by a process that includes fibronectin self-assembly. We found that a 76- amino acid fragment of fibronectin (III1-C) that forms one of the self-assembly sites caused disassembly of preformed fibronectin matrix without affecting cell adhesion. Treating attached fibroblasts or endothelial cells with III1-C inhibited cell migration and proliferation. Rho-dependent stress fiber formation and Rho-dependent focal contact protein phosphorylation were also inhibited, whereas Cdc42 was activated, leading to actin polymerization into filopodia. ACK (activated Cdc42-binding kinase) and p38 MAPK (mitogen-activated protein kinase), two downstream effectors of Cdc42, were activated, whereas PAK (p21-activated kinase) and JNK/SAPK (c-Jun NH2-terminal kinase/ stress-activated protein kinase) were inhibited. III1-C treatment also modulated activation of JNK and ERK (extracellular signal-regulated kinases) in response to growth factors, and reduced the activity of the cyclin E-cdk2 complex. These results indicate that the absence of fibronectin matrix causes activation of Cdc42, and that fibronectin matrix is required for Rho activation and cell cycle progression.

Indexed as

Mitogen-Activated Protein KinasesActinsCalcium-Calmodulin-Dependent Protein Kinasescdc42 GTP-Binding Protein, Saccharomyces cerevisiaeCell CycleCell Cycle ProteinsCytoskeletonEndothelium, VascularEnzyme ActivationExtracellular MatrixFibroblastsFibronectinsGTP-Binding ProteinsGTP PhosphohydrolasesHumansJNK Mitogen-Activated Protein KinasesActinsCalcium-Calmodulin-Dependent Protein Kinasescdc42 GTP-Binding Protein, Saccharomyces cerevisiaeCell Cycle ProteinsFibronectinsGTP-Binding ProteinsGTP PhosphohydrolasesJNK Mitogen-Activated Protein KinasesLamininMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinasesp38 Mitogen-Activated Protein KinasesPeptide FragmentsProtein-Tyrosine KinasesRecombinant ProteinsVitronectin

Identifiers

PMID9763437
PMCPMC2132814
OpenAlexW2041069947

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.